Strategies for specific multimodal imaging of cancer-associated fibroblasts and applications in theranostics of cancer
Source abstract
Abstract
Fibroblast activating protein (FAP) is up-regulated in cancer-associated fibroblasts (CAFs) of more than 90 % of tumor microenvironment and also highly expressed on the surface of multiple tumor cells like glioblastoma, which can be used as a specific target for tumor diagnosis and treatment. At present, small-molecule radiotracer targeting FAP with high specificity exhibit limited functionality, which hinders the integration of theranostics as well as multifunctionality. In this work, we have engineered a multifunctional nanoplatform utilizing organic melanin nanoparticles that specifically targets FAP, facilitating both multimodal imaging and synergistic therapeutic applications. This nanoplatform can perform positron emission tomography (PET), magnetic resonance imaging (MRI) and photoacoustic imaging (PAI) with strong near infrared absorption and metal chelating ability, achieving efficiently targeting accumulation and display long retention in the tumor region. Meanwhile, 131 I-labeled nanoplatform for targeted radioisotope therapy (TRT) and photothermal therapy (PTT) were significantly suppressed tumor growth in glioblastoma xenograft models without obvious side effects. These results demonstrated that this novel nanoparticles-based theranostics nanoplatform can effectively enhance multimodal imaging and targeted radionuclide-photothermal synergistic therapy for solid tumors with FAP expression. Our study introduces unique strategy to enhance multimodal imaging and targeted radionuclide-photothermal synergistic therapy of solid tumor tumors by developing a multifunctional nanoplatform utilizing organic melanin nanoparticles that specifically targets fibroblast activating protein (FAP). Currently, small-molecule radiotracer targeting FAP with high specificity exhibit limited functionality, which hinders the integration of theranostics as well as multifunctionality. We used the high-loading function of melanin nanoparticles to label positron nuclide 64 Cu, paramagnetic metal particle Mn 2+ and label therapeutic nuclide 131 I, together with the optical function function of melanin nanoparticles. This nanoplatform can perform positron emission tomography (PET), magnetic resonance imaging (MRI) and photoacoustic imaging (PAI) with strong near infrared absorption and metal chelating ability, achieving efficiently targeting accumulation and display long retention in the tumor region. Most importantly, 131 I-labeled nanoplatform for targeted radioisotope therapy (RIT) and photothermal therapy (PTT) were significantly suppressed tumor growth in glioblastoma xenograft models without obvious side effects. This innovative strategy capitalizes the excellent biodegradability and biocompatibility of melanin nanoplatforms to provide a promising solution for tumour diagnosis and treatment, while ensuring a high degree of biosafety and in vivo elimination. By combining the advantages of targeted radionuclide-photothermal synergistic therapy, it has the potential to improve treatment outcomes and expanding the clinical utility of RIT/PTT protocols.Scheme 1. Schematic illustration of the theranostic nanoplatform FAPI-PEG-MNs for PET/MR/PA multimodal imaging and radioisotope-photothermal synergistic therapy of glioblastoma.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Peptidase Inhibition and Analysis · Advanced biosensing and bioanalysis techniques · Protease and Inhibitor Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Oncogenesis, microenvironment modulation and clinical potentiality of FAP in glioblastoma: lessons learned from other solid tumors10.3390/cells10051142 ↗
2. The impact of FAP imaging in lung cancer and beyond: a new chapter10.1007/s00330-023-10398-5 ↗
3. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein10.2967/jnumed.118.210443 ↗
4. Correlation of 68Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study10.2967/jnumed.121.262426 ↗
5. Advances in PET imaging of cancer10.1038/s41568-023-00576-4 ↗
6. 68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer
7. Acylated Gly-(2-cyano) pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity10.1016/j.bmcl.2012.03.107 ↗
8. Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis10.7150/thno.88335 ↗
9. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the evaluation of advanced lung cancer10.1148/radiol.211424 ↗
10. Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers10.1148/radiol.2020203275 ↗
11. Nanoprobe-mediated precise imaging and therapy of glioma10.1039/D1NH00182E ↗
12. Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions10.1016/j.jconrel.2022.09.065 ↗
13. Multimodal imaging guided cancer phototherapy by versatile biomimetic theranostics with UV and γ irradiation protection10.1002/adma.201505700 ↗
14. Matrix metalloproteinase-initiated aggregation of melanin nanoparticles as highly efficient contrast agent for enhanced tumor accumulation and dual-modal imaging10.1039/D0TB01651A ↗
15. Chelator-free and biocompatible melanin nanoplatform with facile-loading gadolinium and copper-64 for bioimaging10.1021/acs.bioconjchem.7b00245 ↗
16. A highly specific multiple enhancement theranostic nanoprobe for PET/MRI/PAI image‐guided radioisotope combined photothermal therapy in prostate cancer10.1002/smll.202100378 ↗
17. Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T 1-weighted magnetic resonance imaging10.1021/bm4008138 ↗
18. Indocyanine green–loaded polydopamine–iron ions coordination nanoparticles for photoacoustic/magnetic resonance dual-modal imaging-guided cancer photothermal therapy10.1039/C6NR05502H ↗
19. 64Cu-labeled melanin nanoparticles for PET/CT and radionuclide therapy of tumor
20. RGD-functionalised melanin nanoparticles for intraoperative photoacoustic imaging-guided breast cancer surgery
21. Melanin/melanin-like nanoparticles: as a naturally active platform for imaging-guided disease therapy
22. Engineering melanin nanoparticles as an efficient drug-delivery system for imaging-guided chemotherapy10.1002/adma.201502201 ↗
23. Multimodality imaging of naturally active melanin nanoparticles targeting somatostatin receptor subtype 2 in human small-cell lung cancer10.1039/C9NR04371C ↗
24. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency10.1021/nn500299p ↗
25. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction10.2217/nnm.16.5 ↗
26. An auto-photoacoustic melanin-based drug delivery nano-platform for self-monitoring of acute kidney injury therapy via a triple-collaborative strategy10.1016/j.actbio.2022.05.034 ↗
27. Theranostic radioiodine-labelled melanin nanoparticles inspired by clinical brachytherapy seeds10.1039/C8TB02817F ↗
28. Clearance pathways and tumor targeting of imaging nanoparticles10.1021/acsnano.5b01320 ↗
29. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment10.1016/j.addr.2014.05.005 ↗
30. interfaces, Collagenase-encapsulated pH-responsive nanoscale coordination polymers for tumor microenvironment modulation and enhanced photodynamic nanomedicine10.1021/acsami.8b17684 ↗
31. A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles10.1016/j.carbpol.2018.12.074 ↗
32. Mechanism investigation of hyaluronidase-combined multistage nanoparticles for solid tumor penetration and antitumor effect10.2147/IJN.S257164 ↗
33. Water soluble melanin derivatives for dynamic contrast enhanced photoacoustic imaging of tumor vasculature and response to antiangiogenic therapy10.1002/adhm.201600550 ↗
34. Mn2+-coordinated PDA@ DOX/PLGA nanoparticles as a smart theranostic agent for synergistic chemo-photothermal tumor therapy10.2147/IJN.S132270 ↗
35. Ultrasmall ferrite nanoparticles synthesized via dynamic simultaneous thermal decomposition for high-performance and multifunctional T 1 magnetic resonance imaging contrast agent10.1021/acsnano.6b07684 ↗